PHENOBARBITAL SODIUM INJECTION 120MG/ML DIN 00497495
Health Canada record
| Active ingredient(s) | PHENOBARBITAL SODIUM 120 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intramuscular |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | N03AA02 PHENOBARBITAL |
| Original market date | 31-Dec-1981 |
| Current status date | 03-Aug-2012 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hospira Healthcare India Pvt. Ltd. — licence , not currently licensed, last inspection rating NC (2017-07-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PHENOBARBITAL SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02304090 | PHENOBARBITAL SODIUM INJECTION, USP | SANDOZ CANADA INCORPORATED | Solution | PHENOBARBITAL SODIUM 120 MG | Marketed |
| 02304082 | PHENOBARBITAL SODIUM INJECTION, USP | SANDOZ CANADA INCORPORATED | Solution | PHENOBARBITAL SODIUM 30 MG | Marketed |
| 00497487 | PHENOBARBITAL SODIUM INJECTION 30MG/ML | HOSPIRA HEALTHCARE ULC | Solution | PHENOBARBITAL SODIUM 30 MG | Cancelled Post Market |
International API supply for PHENOBARBITAL SODIUM
1 valid EDQM Certificates of Suitability from 1 holders. 3 active FDA Drug Master Files.
Request a quote for PHENOBARBITAL SODIUM INJECTION 120MG/ML